Soluscope SAS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Soluscope SAS - overview
Established
1994
Location
Aubagne, -, France
Primary Industry
Medical Devices & Equipment
About
Soluscope SAS is a French company specializing in endoscope reprocessing, focusing on the design and manufacture of advanced cleaning and disinfection solutions for healthcare facilities. Founded in 1994 and headquartered in Aubagne, France, Soluscope SAS specializes in the reprocessing of endoscopes. In April 2014, the company was acquired by Laboratoires Anios S. A.
, a portfolio company of Ardian. The acquisition aimed to enhance their product offerings and market reach. Soluscope specializes in endoscope reprocessing, designing, developing, and manufacturing a comprehensive range of products that address the complexities of cleaning, disinfecting, and storing endoscopes. Their core product offerings include advanced washer-disinfectors tailored for various types of flexible endoscopes, including those used in gastroenterology, pulmonology, cardiology, and ENT applications.
The company also provides horizontal and vertical storage cabinets that ensure safe and hygienic storage of endoscopes, as well as innovative digital solutions like the EP-Digital suite to enhance workflow and hygiene practices. Soluscope’s customers primarily consist of healthcare facilities and professionals across over 50 countries, ensuring patient safety and operational efficiency in the medical sector. Their commitment to high-quality, French-made products showcases their dedication to meeting the rigorous standards of modern healthcare. In the most recent year 2024, Soluscope reported revenue of USD 34.
68 mn with an EBITDA of USD 3. 49 mn. The company generates revenue through the sale of its specialized endoscope reprocessing solutions, which includes flagship products such as the Soluscope Sprint PT pass-through washer-disinfector. The company engages in direct business-to-business (B2B) transactions with healthcare providers, ensuring that their products are effectively integrated into medical facilities' workflows.
Although specific new products have not been announced, Soluscope aims to enhance its offerings in the endoscope reprocessing market to meet evolving healthcare demands. The company is focused on expanding into new markets, particularly targeting regions in Europe and North America by 2025. The acquisition by Laboratoires Anios S. A.
is expected to support these expansion efforts, enabling Soluscope to leverage greater resources and distribution networks to enhance its market presence.
Current Investors
Laboratoires Anios S.A.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors
Website
www.soluscope.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Soluscope SAS - financials
| Fiscal Year Ended | Dec 31, 2016 | Nov 30, 2017 | Nov 30, 2018 | Nov 30, 2019 | Nov 30, 2020 | Nov 30, 2021 | Nov 30, 2022 | Nov 30, 2023 | Nov 30, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 28,053,119 | 25,486,801 | 24,352,264 | 24,717,622 | 26,409,547 | 24,536,626 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | 1.5% | 6.8% | (7.1%) | - | - | - |
| EBITDA (USD) | 5,792,073 | 2,858,230 | (199,488) | 1,096,499 | 2,612,628 | 859,253 | - | - | - |
| Operating Income (USD) | 5,447,242 | 2,496,920 | (568,678) | 766,973 | 2,204,491 | 507,094 | - | - | - |
| Operating Margin | 19.4% | 9.8% | (2.3%) | 3.1% | 8.3% | 2.1% | - | - | - |
| % EBITDA Margin | 20.6% | 11.2% | (0.8%) | 4.4% | 9.9% | 3.5% | - | - | - |
| NET Income (USD) | 3,529,891 | 7,010,844 | (852,517) | 700,369 | 1,620,906 | 242,155 | - | - | - |
| % Net Margin | 12.6% | 27.5% | (3.5%) | 2.8% | 6.1% | 1.0% | - | - | - |
Soluscope SAS - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Soluscope SAS | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.